ArticleScientific reports2025
Assessment of health-related quality of life in transfusion dependent beta thalassemia.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Research on health-related quality of life (HRQoL) among thalassemia patients in Jordan remains limited. This study aimed to evaluate HRQoL outcomes in patients with thalassemia and examine associations with psychosocial, medical, and clinical factors. A cross-sectional study was conducted among β-thalassemia major patients attending the Thalassemia Unit at Princess Rahma Educational Hospital for Children. HRQoL was assessed using a validated Arabic version of the Medical Outcomes Study Short Form (SF-36). A total of 285 patients were enrolled, with a mean age of 20.23 years; 55.1% were male. Lower mental health scores were associated with male gender, higher education, and non-smoking status. Poor physical functioning was linked to male gender, smoking, and not receiving anticoagulant therapy. Lower pain scores were observed among males and those not on anticoagulants. Vitality was significantly lower in males. Absence of comorbidities was linked to better role functioning, while non-smoking and higher income were associated with improved general health perception. Male gender, lower income, absence of splenectomy, and not using anticoagulant therapy were associated with poorer HRQoL outcomes. Overall, male patients reported lower HRQoL than females. Targeted national healthcare strategies are essential to enhance HRQoL among thalassemia patients in Jordan.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.